Errors in Clinical Data & Trial Management Coverage
Errors in Clinical Data & Trial Management Insurance protects pharmaceutical companies, biotechnology firms, research organizations, laboratories, and clinical trial sponsors against the financial, operational, and liability exposures arising from errors, omissions, or failures in clinical trial administration, data handling, research management, and regulatory processes.
Coverage is designed to support financial stability and operational continuity when inaccuracies, procedural failures, or administrative errors impact clinical research activities or trial outcomes.
Coverage typically responds to losses involving inaccurate clinical data, trial management errors, protocol deviations, reporting failures, documentation issues, regulatory non-compliance, or third-party financial loss arising from the administration or oversight of clinical studies and research operations.
Coverage may also include protection for:
Clinical trial administration and data management errors
Protocol deviations and regulatory reporting failures
Loss or corruption of research and clinical data
Legal defense costs, investigations, settlements, and regulatory proceedings
Business interruption and operational disruption arising from covered incidents
Coverage supporting pharmaceutical, biotechnology, healthcare, laboratory, and medical research operations
For organizations operating across multiple jurisdictions, coverage may be coordinated through a Controlled Master Program (CMP), such as the WMB Global Risks Global Master Program, with locally admitted policies where required to support coordinated protection and regulatory compliance across jurisdictions.
Errors in Clinical Data & Trial Management Insurance is designed to help organizations manage complex research and operational risks, protect financial stability, and maintain continuity throughout clinical and medical research operations.